Skip to main content

ARDSLEY ADVISORY PARTNERS LP

Position in ALDX — Aldeyra Therapeutics, Inc.

CIK 900529 Norwalk, CT

Position in ALDX

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$2,076,750
+$471,250 QoQ
Shares Held
975,000
+2.6% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#12
of 108 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALDX Over Time

Shares Held

Position Value (USD)

Derivatives in ALDX

reported options exposure · as of Jun 30, 2026
CallValue
$639,000
CallShares
300,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ARDSLEY ADVISORY PARTNERS LP holds $24,823,800 across 5 Biotechnology names. ALDX ranks #5 (8.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ALDX
Aldeyra Therapeutics, Inc.
This page
975,000 $2,076,750

All Filings in ALDX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $639,000 300,000
2026-06-30 $2,076,750 975,000
2026-03-31 $1,605,500 950,000
2026-03-31 $507,000 300,000
2025-12-31 $7,511,000 1,450,000
2025-12-31 $259,000 50,000
2025-09-30 $9,918,000 1,900,000
2025-06-30 $7,851,500 2,050,000
2025-03-31 $10,062,500 1,750,000
2025-03-31 $2,300,000 400,000
2024-12-31 $2,994,000 600,000
2024-12-31 $5,738,500 1,150,000
2024-09-30 $2,695,000 500,000
2020-09-30 $460,161 62,100
2020-06-30 $258,957 62,100
2020-03-31 $91,637 37,100